These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2427185)

  • 1. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease.
    Gordon AN; Kavanagh JJ; Gershenson DM; Saul PB; Copeland LJ; Stringer CA
    Cancer; 1986 Oct; 58(7):1407-10. PubMed ID: 2427185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein M
    J Reprod Med; 1989 Mar; 34(3):189-92. PubMed ID: 2470902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.
    Azab M; Droz JP; Theodore C; Wolff JP; Amiel JL
    Cancer; 1989 Nov; 64(9):1829-32. PubMed ID: 2477136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).
    Hainsworth JD; Burnett LS; Jones HW; Greco FA
    Cancer Treat Rep; 1983 Apr; 67(4):393-5. PubMed ID: 6189602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
    Willemse PH; Aalders JG; Bouma J; Sleijfer DT
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor-prognosis gestational trophoblastic disease: an update.
    Surwit EA; Alberts DS; Christian CD; Graham VE
    Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
    Theodore C; Azab M; Droz JP; Assouline A; George M; Piot G; Bellet D; Michel G; Amiel JL
    Cancer; 1989 Nov; 64(9):1824-8. PubMed ID: 2551474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
    Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
    Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
    Gallion HH; van Nagell JR; Donaldson ES; Higgins RV
    Gynecol Oncol; 1989 Jul; 34(1):98-100. PubMed ID: 2544491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
    J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Gynecol Oncol; 1986 May; 24(1):51-7. PubMed ID: 2422094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
    Carlson RW; Sikic BI; Turbow MM; Ballon SC
    J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, vinblastine, and bleomycin as second-trial therapy in ovarian carcinoma. A pilot study of the Gynecologic Oncology Group.
    Stehman FB; Ehrlich CE; Williams SD; Einhorn LH
    Am J Clin Oncol; 1985 Feb; 8(1):27-31. PubMed ID: 2581434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.